144 related articles for article (PubMed ID: 37301805)
21. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
Al-Samkari H; Karp Leaf RS; Dzik WH; Carlson JCT; Fogerty AE; Waheed A; Goodarzi K; Bendapudi PK; Bornikova L; Gupta S; Leaf DE; Kuter DJ; Rosovsky RP
Blood; 2020 Jul; 136(4):489-500. PubMed ID: 32492712
[TBL] [Abstract][Full Text] [Related]
22. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
Aktaa S; Wu J; Nadarajah R; Rashid M; de Belder M; Deanfield J; Mamas MA; Gale CP
Thromb Res; 2021 Jun; 202():17-23. PubMed ID: 33711754
[TBL] [Abstract][Full Text] [Related]
23. Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study.
Al Harbi S; Kensara R; Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Vishwakarma R; Alenazi AM; Almutairi A; Alshaya O; Alraddadi S; Al Sulaiman T; Aldakkan L; Mahboob R; Alaamer K; Alissa A; Hafiz A; Aldhayyan N; Althewaibi S; Alenezi F; Alkhotani NY; Alghamdi SA; Alenazi AA; Al Sulaiman K
Clin Appl Thromb Hemost; 2022; 28():10760296221103864. PubMed ID: 35658686
[TBL] [Abstract][Full Text] [Related]
24. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
[TBL] [Abstract][Full Text] [Related]
25. Incidence of venous thromboembolism in hospitalized patients with COVID-19.
Middeldorp S; Coppens M; van Haaps TF; Foppen M; Vlaar AP; Müller MCA; Bouman CCS; Beenen LFM; Kootte RS; Heijmans J; Smits LP; Bonta PI; van Es N
J Thromb Haemost; 2020 Aug; 18(8):1995-2002. PubMed ID: 32369666
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection.
Obispo B; Rogado J; Muñoz-Rivas N; Pangua C; Serrano G; Lara MA;
Med Clin (Barc); 2022 Sep; 159(5):234-237. PubMed ID: 34674859
[TBL] [Abstract][Full Text] [Related]
27. Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19.
Patell R; Bogue T; Bindal P; Koshy A; Merrill M; Aird WC; Bauer KA; Zwicker JI
J Thromb Haemost; 2020 Sep; 18(9):2349-2357. PubMed ID: 32692862
[TBL] [Abstract][Full Text] [Related]
28. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
29. The incidence and clinical impact of thrombotic events in hospitalized COVID-2019 illness.
Singh B; Dhooria HP; Mohan B; Goyal A; Singh G; Singh P; Goyal M; Luthra S; Chhabra ST; Tandon R; Aslam N; Wander GS
Int Angiol; 2022 Aug; 41(4):356-363. PubMed ID: 35373940
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection.
Rubini-Costa R; Bermúdez-Jiménez F; Rivera-López R; Sola-García E; Nagib-Raya H; Moreno-Escobar E; López-Zúñiga MÁ; Briones-Través A; Sanz-Herrera F; Sequí-Sabater JM; Romero-Cabrera JL; Maíllo-Seco J; Fernández-Vázquez F; Rivadeneira-Ruiz M; López-Valero L; Gómez-Navarro C; Aparicio-Gómez JA; López MÁ; Tercedor L; Molina-Jiménez M; Macías-Ruiz R; Jiménez-Jáimez J
Med Clin (Barc); 2022 Jun; 158(12):569-575. PubMed ID: 34364707
[TBL] [Abstract][Full Text] [Related]
31. Thrombosis and hemorrhage experienced by hospitalized children with SARS-CoV-2 infection or MIS-C: Results of the PICNIC registry.
Tehseen S; Williams S; Robinson J; Morris SK; Bitnun A; Gill P; Tal TE; Yeh A; Yea C; Ulloa-Gutierrez R; Brenes-Chacon H; Yock-Corrales A; Ivankovich-Escoto G; Soriano-Fallas A; Papenburg J; Lefebvre MA; Scuccimarri R; Nateghian A; Aski BH; Dwilow R; Bullard J; Cooke S; Restivo L; Lopez A; Sadarangani M; Roberts A; Forbes M; Saux NL; Bowes J; Purewal R; Lautermilch J; Bayliss A; Wong JK; Leifso K; Foo C; Panetta L; Kakkar F; Piche D; Viel-Theriault I; Merckx J; Lieberman L
Pediatr Blood Cancer; 2022 Sep; 69(9):e29793. PubMed ID: 35689507
[TBL] [Abstract][Full Text] [Related]
32. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
[TBL] [Abstract][Full Text] [Related]
33. Outcomes in patients discharged with extended venous thromboembolism prophylaxis after hospitalization with COVID-19.
Patel L; Stenzel A; Van Hove C; Sidebottom A; Kethireddy R; Ha N; Beddow D; Manunga J; Qadri G; Kirven J; Skeik N
Vasc Med; 2023 Aug; 28(4):331-339. PubMed ID: 37259526
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status.
Li W; Xu Z; Xiang H; Zhang C; Guo Y; Xiong J
Aging (Albany NY); 2021 Mar; 13(7):9225-9242. PubMed ID: 33818421
[TBL] [Abstract][Full Text] [Related]
35. Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.
Cánovas MS; Garay DF; Moran LO; Pérez JR; Rubio CMG; de Mena ML; Portero BO; Castro JB; Lage Y; Lavin DC; Blanco ABR; de Soignie AMMF; Perejón JZB; Colomo LJ; Boluda NB; Moreno JB; Verduguez TQ; Garrido CR; Huertas RM; Puig CFI; Martín AJM
Clin Transl Oncol; 2022 Oct; 24(10):2010-2020. PubMed ID: 35668339
[TBL] [Abstract][Full Text] [Related]
36. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study.
Katsoularis I; Fonseca-Rodríguez O; Farrington P; Jerndal H; Lundevaller EH; Sund M; Lindmark K; Fors Connolly AM
BMJ; 2022 Apr; 377():e069590. PubMed ID: 35387772
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
[TBL] [Abstract][Full Text] [Related]
38. Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy.
Bozzani A; Arici V; Tavazzi G; Franciscone MM; Danesino V; Rota M; Rossini R; Sterpetti AV; Ticozzelli G; Rumi E; Mojoli F; Bruno R; Ragni F
Surgery; 2020 Dec; 168(6):987-992. PubMed ID: 33039110
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.
Bellmunt-Montoya S; Riera C; Gil D; Rodríguez M; García-Reyes M; Martínez-Carnovale L; Marrero C; Gil M; Ruiz-Rodríguez JC; Ferrer R; de Nadal M; Monreal M; Llagostera S
Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):628-634. PubMed ID: 33583710
[TBL] [Abstract][Full Text] [Related]
40. Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study.
Hill JB; Garcia D; Crowther M; Savage B; Peress S; Chang K; Deitelzweig S
Blood Adv; 2020 Nov; 4(21):5373-5377. PubMed ID: 33137202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
